| Dr William Elias Morrow, DO | |
|
1700 Geary St Se Ste 200, Albany, OR 97322-6842 | |
| (541) 812-5570 | |
| Not Available |
| Full Name | Dr William Elias Morrow |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 1700 Geary St Se Ste 200, Albany, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659729986 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | PG177167 (Oregon) | Secondary |
| 207Q00000X | Family Medicine | DO192878 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Signature Healthcare At Home | Eugene, OR | Home health agency |
| Samaritan Albany General Hospital | Albany, OR | Hospital |
| Good Samaritan Regional Medical Center | Corvallis, OR | Hospital |
| Samaritan Lebanon Community Hospital | Lebanon, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Good Samaritan Hospital Corvallis | 1557270725 | 339 |
| Albany General Hospital | 9931097987 | 162 |
News Archive
Researchers at the Icahn School of Medicine at Mount Sinai reported that a virulent new strain of influenza - the virus that causes the flu - appears to retain its ability to cause serious disease in humans even after it develops resistance to antiviral medications. The finding was included in a study that was published today in the journal Nature Communications.
Chronic back pain is the leading cause of disability worldwide. In the United States, patients spend up to $300 billion each year to treat the condition, according to a 2012 study published in the Journal of Pain.
The nighttime breathing disorder known as obstructive sleep apnea increases a person's risk of having a heart attack or dying by 30% over a period of four to five years, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.
Most humans would like to shed their fatty exteriors, but tuberculosis (TB)-causing bacteria rely on theirs for survival. Scientists at the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School have now discovered a drug that cripples the TB bug by dissolving its protective fatty coating, a finding that could eventually be used to improve TB treatment in humans. The study has been posted online by Nature Chemical Biology.
› Verified 3 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20031111000297 |
News Archive
Researchers at the Icahn School of Medicine at Mount Sinai reported that a virulent new strain of influenza - the virus that causes the flu - appears to retain its ability to cause serious disease in humans even after it develops resistance to antiviral medications. The finding was included in a study that was published today in the journal Nature Communications.
Chronic back pain is the leading cause of disability worldwide. In the United States, patients spend up to $300 billion each year to treat the condition, according to a 2012 study published in the Journal of Pain.
The nighttime breathing disorder known as obstructive sleep apnea increases a person's risk of having a heart attack or dying by 30% over a period of four to five years, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.
Most humans would like to shed their fatty exteriors, but tuberculosis (TB)-causing bacteria rely on theirs for survival. Scientists at the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School have now discovered a drug that cripples the TB bug by dissolving its protective fatty coating, a finding that could eventually be used to improve TB treatment in humans. The study has been posted online by Nature Chemical Biology.
› Verified 3 days ago
| Entity Name | Good Samaritan Hospital Corvallis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962453134 PECOS PAC ID: 1557270725 Enrollment ID: O20031125000163 |
News Archive
Researchers at the Icahn School of Medicine at Mount Sinai reported that a virulent new strain of influenza - the virus that causes the flu - appears to retain its ability to cause serious disease in humans even after it develops resistance to antiviral medications. The finding was included in a study that was published today in the journal Nature Communications.
Chronic back pain is the leading cause of disability worldwide. In the United States, patients spend up to $300 billion each year to treat the condition, according to a 2012 study published in the Journal of Pain.
The nighttime breathing disorder known as obstructive sleep apnea increases a person's risk of having a heart attack or dying by 30% over a period of four to five years, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.
Most humans would like to shed their fatty exteriors, but tuberculosis (TB)-causing bacteria rely on theirs for survival. Scientists at the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School have now discovered a drug that cripples the TB bug by dissolving its protective fatty coating, a finding that could eventually be used to improve TB treatment in humans. The study has been posted online by Nature Chemical Biology.
› Verified 3 days ago
| Entity Name | Albany General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154372340 PECOS PAC ID: 9931097987 Enrollment ID: O20040310000310 |
News Archive
Researchers at the Icahn School of Medicine at Mount Sinai reported that a virulent new strain of influenza - the virus that causes the flu - appears to retain its ability to cause serious disease in humans even after it develops resistance to antiviral medications. The finding was included in a study that was published today in the journal Nature Communications.
Chronic back pain is the leading cause of disability worldwide. In the United States, patients spend up to $300 billion each year to treat the condition, according to a 2012 study published in the Journal of Pain.
The nighttime breathing disorder known as obstructive sleep apnea increases a person's risk of having a heart attack or dying by 30% over a period of four to five years, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.
Most humans would like to shed their fatty exteriors, but tuberculosis (TB)-causing bacteria rely on theirs for survival. Scientists at the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School have now discovered a drug that cripples the TB bug by dissolving its protective fatty coating, a finding that could eventually be used to improve TB treatment in humans. The study has been posted online by Nature Chemical Biology.
› Verified 3 days ago
| Entity Name | Mid-valley Healthcare Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1689625980 PECOS PAC ID: 2769391523 Enrollment ID: O20061104000140 |
News Archive
Researchers at the Icahn School of Medicine at Mount Sinai reported that a virulent new strain of influenza - the virus that causes the flu - appears to retain its ability to cause serious disease in humans even after it develops resistance to antiviral medications. The finding was included in a study that was published today in the journal Nature Communications.
Chronic back pain is the leading cause of disability worldwide. In the United States, patients spend up to $300 billion each year to treat the condition, according to a 2012 study published in the Journal of Pain.
The nighttime breathing disorder known as obstructive sleep apnea increases a person's risk of having a heart attack or dying by 30% over a period of four to five years, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.
Most humans would like to shed their fatty exteriors, but tuberculosis (TB)-causing bacteria rely on theirs for survival. Scientists at the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School have now discovered a drug that cripples the TB bug by dissolving its protective fatty coating, a finding that could eventually be used to improve TB treatment in humans. The study has been posted online by Nature Chemical Biology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Elias Morrow, DO Po Box 1188, Corvallis, OR 97339-1188 Ph: () - | Dr William Elias Morrow, DO 1700 Geary St Se Ste 200, Albany, OR 97322-6842 Ph: (541) 812-5570 |
News Archive
Researchers at the Icahn School of Medicine at Mount Sinai reported that a virulent new strain of influenza - the virus that causes the flu - appears to retain its ability to cause serious disease in humans even after it develops resistance to antiviral medications. The finding was included in a study that was published today in the journal Nature Communications.
Chronic back pain is the leading cause of disability worldwide. In the United States, patients spend up to $300 billion each year to treat the condition, according to a 2012 study published in the Journal of Pain.
The nighttime breathing disorder known as obstructive sleep apnea increases a person's risk of having a heart attack or dying by 30% over a period of four to five years, according to a study presented at the American Thoracic Society 2007 International Conference, on Monday, May 21.
Most humans would like to shed their fatty exteriors, but tuberculosis (TB)-causing bacteria rely on theirs for survival. Scientists at the University of Medicine and Dentistry of New Jersey (UMDNJ)-New Jersey Medical School have now discovered a drug that cripples the TB bug by dissolving its protective fatty coating, a finding that could eventually be used to improve TB treatment in humans. The study has been posted online by Nature Chemical Biology.
› Verified 3 days ago
Damian E Jorgensen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 633 N Albany Rd Nw, Albany, OR 97321 Phone: 541-926-3441 | |
Dr. Katherine Merkle, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 534 Pleasant View Way Nw Ste 100, Albany, OR 97321 Phone: 541-812-5656 | |
Dr. John R. Ward Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Geary St Se Ste 200, Albany, OR 97322 Phone: 541-812-5570 | |
Dr. Stephen Joel Hallas, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 534 Pleasant View Way Nw Ste 100, Albany, OR 97321 Phone: 541-812-5656 | |
Elizabeth A Robb, Family Medicine Medicare: Medicare Enrolled Practice Location: 1700 Geary St Se Ste 200, Albany, OR 97322 Phone: 541-812-5570 | |
Rebecca L Pengilly, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1705 Waverly Dr Se, Albany, OR 97322 Phone: 541-967-8221 | |
Ms. Kea Michelle Crandall, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1046 6th Ave Sw, Albany, OR 97321 Phone: 541-812-4000 Fax: 541-812-4126 |